Recent Finacing
Recent Raise
Frontier Medicines is a clinical-stage precision‑medicine company that uses a chemoproteomics, covalent‑chemistry, and machine‑learning drug‑discovery platform to develop oncology and immunology small‑molecule therapies, including dual ON/OFF KRASG12C inhibitors.
